Compounds > technetium-tc-99m-tetrofosmin

technetium-tc-99m-tetrofosmin and Castleman-Disease

technetium-tc-99m-tetrofosmin has been researched along with Castleman-Disease* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-tetrofosmin and Castleman-Disease

Article	Year
Scintigraphic evaluation of cardiac metabolism in multicentric Castleman's disease. Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:6 A 72-year-old woman had insidious onset of heart failure, and was diagnosed as multicentric Castleman's disease. She underwent myocardial imaging with technetium-99m tetrofosmin, 1-123 beta-methyl-iodophenyl pentadecanoic acid (BMIPP). Technetium-99m tetrofosmin studies showed almost normal uptake of the left ventricular myocardium indicating normal myocardial perfusion. 1-123 BMIPP showed reduced uptake in the apical segment of the myocardium, indicating regional fatty acid metabolic abnormalities. Topics: Aged; Castleman Disease; Fatty Acids; Female; Heart Failure; Humans; Iodobenzenes; Metabolic Diseases; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon	2004

Article

Year

Scintigraphic evaluation of cardiac metabolism in multicentric Castleman's disease.

Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:6

A 72-year-old woman had insidious onset of heart failure, and was diagnosed as multicentric Castleman's disease. She underwent myocardial imaging with technetium-99m tetrofosmin, 1-123 beta-methyl-iodophenyl pentadecanoic acid (BMIPP). Technetium-99m tetrofosmin studies showed almost normal uptake of the left ventricular myocardium indicating normal myocardial perfusion. 1-123 BMIPP showed reduced uptake in the apical segment of the myocardium, indicating regional fatty acid metabolic abnormalities.

Topics: Aged; Castleman Disease; Fatty Acids; Female; Heart Failure; Humans; Iodobenzenes; Metabolic Diseases; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon

2004